Physician profile
John Peacock
NPI 1700883725
$3,790.55
in general payments reported to CMS, 2019-2025
32 companies · $649 in 2025
The $649 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $239 · 2021: $421 · 2022: $364 · 2023: $600 · 2024: $1,129 · 2025: $649.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,312 · Education: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,312.29 |
| Education | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $792.96 | 2019-2025 | Veozah, Myrbetriq, Xtandi |
| Sumitomo Pharma America, INC. | $530.88 | 2023-2025 | Orgovyx, Gemtesa |
| Coloplast Corp | $481.48 | 2019-2025 | Titan |
| Axonics, INC. | $272.23 | 2022-2024 | Axonics |
| Boston Scientific Corporation | $247.50 | 2019-2025 | Axonics, Lumenis Pulse 120h |
| Janssen Biotech, INC. | $207.10 | 2019-2025 | Erleada, Akeega |
| Endo Pharmaceuticals INC. | $182.88 | 2019-2023 | Aveed, Xiaflex, Edex |
| Pfizer INC. | $135.16 | 2022-2025 | |
| Procept Biorobotics Corporation | $128.73 | 2022-2024 | Aquabeam System |
| Medtronic, INC. | $96.25 | 2025 | Interstim |
| Isoray, INC | $82.88 | 2023 | Brachytherapy Source |
| Tolmar, INC. | $70.44 | 2023-2024 | |
| Endo USA, INC. | $62.19 | 2024-2025 | Aveed, Xiaflex |
| Antares Pharma, INC. | $61.38 | 2023-2025 | Xyosted, Nocdurna, Tlando |
| Abbvie INC. | $56.64 | 2023-2024 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $53.54 | 2019-2021 | |
| Myovant Sciences INC. | $32.13 | 2021 | |
| Laborie Medical Technologies Corp. | $31.03 | 2024 | Urgent Pc Neuromodulation System |
| Amgen INC. | $28.09 | 2019-2021 | |
| Teleflex LLC | $26.10 | 2021 | |
| Abc Home Medical Supply, INC. | $24.14 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.27 | 2019 | |
| Alnylam Pharmaceuticals INC. | $19.88 | 2023 | Oxlumo |
| Novartis Pharmaceuticals Corporation | $19.70 | 2025 | |
| Halozyme INC | $18.41 | 2023 | |
| C. R. Bard, INC. & Subsidiaries | $16.61 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $16.55 | 2019 | |
| Rochester Medical Corporation | $15.73 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.71 | 2024 | |
| Ambu INC. | $15.33 | 2024 | |
| Travere Therapeutics, INC. | $14.87 | 2020 | |
| Olympus America INC. | $12.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Peacock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.